Allianz Asset Management
CSBR icon

Allianz Asset Management’s Champions Oncology CSBR Stock Holding History

Allianz Asset Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-64,904
Closed -$508K – 2741
2019
Q2 		$508K Buy
64,904
+966
+2% +$8.47K ﹤0.01% 2346
2019
Q1 		$626K Sell
63,938
-796
-1% -$7.93K ﹤0.01% 2252
2018
Q4 		$506K Buy
+64,734
New +$743K ﹤0.01% 2265

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Allianz Asset Management's CSBR Position: Q3 2019 in Review

Allianz Asset Management sold out of Champions Oncology (CSBR) in Q3 2019, closing a stake of 64,904 shares — an estimated $508K sold.

Allianz Asset Management first reported a position in CSBR in Q4 2018 and held it in 3 quarters. The position peaked at $626K in Q1 2019. 33 funds tracked by Wall St. Rank hold CSBR as of Q3 2019.

  • Allianz Asset Management reported no remaining Champions Oncology position as of Q3 2019 after selling out during the quarter.
  • Allianz Asset Management sold 64,904 Champions Oncology shares in Q3 2019, an estimated $508K.
  • Allianz Asset Management first reported a position in Champions Oncology in Q4 2018 and held it in 3 quarters.
  • Allianz Asset Management's Champions Oncology position peaked at $626K in Q1 2019.
  • 33 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2019.

Based on Allianz Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.